Abilify and Treatment Noncompliance

This page shows results related to Abilify and Treatment Noncompliance from the FDA Adverse Event Reporting System (AERS).

Adverse Event

Safe Use Tools

Learn More

Comments

Abilify and Treatment Noncompliance

Age

30-39 Years	22
20-29 Years	18
40-49 Years	16
10-19 Years	10
>60 Years	9
50-59 Years	4
1-9 Years	2

Gender

Male: 48%
Female: 52%

Outcome

What were the most common outcomes of those reporting Treatment Noncompliance?

Hospitalization	45
Other	43
Death	18
Life Threatening	7
Disability	2

Reporter

Who most commonly reported Treatment Noncompliance?

Other	33
Physician	25
Consumer	23
Pharmacist	5
Lawyer	2

Therapy

Of those reporting Treatment Noncompliance, why were they taking Abilify?

Schizophrenia	25
Bipolar Disorder	16
Psychotic Disorder	9
Schizoaffective Disorder	9
Schizophrenia, Paranoid Type	4

Other Medications

Which medications reported to the FDA are most commonly associated with Treatment Noncompliance?

Fosamax	564
Duragesic-100	542
Clozaril	472
Vioxx	427
Claravis	334
	Show More
Digoxin	325
Risperdal	311
Zyprexa	271
Clozapine	239
Prograf	223
Exjade	215
Nicotine	212
Neurontin	211
Fentanyl Transdermal System	207
Lipitor	198
Risperidone	198
Celebrex	181
Risperdal Consta	178
Dianeal	171
Seroquel	169
Avonex	156
Fentanyl-100	145
Zoloft	143
Isotretinoin	142
Nuvaring	141
Foraseq	136
Paxil	136
Rebif	135
Accutane	133
Lamictal	131
Amnesteem	126
Fentanyl Citrate	122
Keppra	120
Forteo	113
Oxycontin	112
Lexapro	108
Lyrica	107
Advair Diskus 100/50	107
Humira	103
Peg-intron	102
Effexor Xr	101
Abilify	99
Cymbalta	99
Gleevec	97
Actos	91
Ribavirin	91
Diovan	90
Humalog	85
Chantix	85
Topamax	84
Revlimid	80

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.^*

	YES	NO	UNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?

Probability of an Adverse Event

Doubtful

Possible

Probable

Definite

^*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Abilify, view the complete Abilify adverse event report.

Scientific Publications on Treatment Noncompliance

Comments

Share your experience with Abilify and Treatment Noncompliance.